A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 Vaginal Ring) in Women With Moderate to Severe Primary Dysmenorrhea

Trial Profile

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Study the Efficacy and Safety of MK-8342B (ENG-E2 Vaginal Ring) in Women With Moderate to Severe Primary Dysmenorrhea

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Estradiol/etonogestrel (Primary)
  • Indications Dysmenorrhoea
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 23 Nov 2016 This trial has been discontinued in Poland.
    • 06 Oct 2016 This trial is completed in Sweden (end date:12-09-2016), according to the European Clinical Trials Database record.
    • 10 Aug 2016 Planned End Date changed from 1 Mar 2017 to 1 Sep 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top